Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.
Vallera
D A
DA
D000293:Adolescent; D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D000922:Immunotoxins / Q000276:immunology / Q000627:therapeutic use*; D007223:Infant; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D007942:Leukemia, Experimental / Q000276:immunology / Q000601:surgery; D008212:Lymphocyte Depletion; D051379:Mice; D008875:Middle Aged; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000276:immunology; D011300:Preoperative Care; D011868:Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D051381:Rats; D014118:Toxins, Biological / Q000494:pharmacology / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D000922:Immunotoxins; D011868:Radioisotopes; D014118:Toxins, Biological